LIC reduces stake in Sun Pharma, sells shares worth Rs 3,882 crore in a little over one year
PTI, Jul 26, 2022, 9:54 AM IST
Credit: Reuters photo
Life Insurance Corporation on Monday said it has reduced shareholding in Sun Pharmaceuticals by selling 2 per cent stake in the company for about Rs 3,882 crore.
The shares were sold through open market transactions during the period from May 17, 2021 to July 22, 2022, according to a regulatory filing.
“This is to inform that corporation’s shareholding in Sun Pharamceuticals has diluted from 16,85,66,486 to 12,05,24,944 equity shares, decreasing its shareholding from 7.026 per cent of the paid-up capital of the said company,” it said.
Under Sebi norms, listed companies are required to intimate the stock exchanges when their shareholding in an entity falls by 2 per cent or more.
The shares were sold at an average price of Rs 808.02 apiece, valuing the transactions at a total of Rs 3,881.85 crore.
On the BSE, shares of LIC (Life Insurance Corporation) declined 0.70 per cent to close at Rs 684.15 apiece while that of Sun Pharmaceuticals fell 0.75 per cent to Rs 868.05 apiece.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
RBI: After another status quo year, all eyes on a growth-propping rate cut with new Guv at helm
Front-running case: Sebi bans 9 entities from market , impounds illegal gains of over Rs 21 crore
Global trends, FIIs’ move to dictate trends in markets in holiday-shortened week: Analysts
GST Council postpones decision to cut tax on insurance, rate panel defers report submission
GST Council meet to decide on lower taxes on insurance policies, ATF inclusion
MUST WATCH
Latest Additions
Notorious gangster wanted in UAPA case arrested at Nepal border
Mandhana, Renuka blow away West Indies in first ODI
‘Condition critical’, say doctors as farmer leader Dallewal’s fast enters 27th day
ISRO to study how crops grow in space on PSLV-C60 mission
Vandalism at Allu Arjun’s residence in Hyderabad
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.